Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 15 studies | 30% ± 8% | |
lung | 9 studies | 24% ± 6% | |
lymph node | 4 studies | 22% ± 4% | |
intestine | 4 studies | 22% ± 9% | |
pancreas | 3 studies | 33% ± 10% | |
placenta | 3 studies | 35% ± 11% | |
brain | 3 studies | 24% ± 4% | |
liver | 3 studies | 23% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9844.90 | 1445 / 1445 | 100% | 113.76 | 183 / 183 |
lung | 100% | 9885.54 | 578 / 578 | 100% | 134.17 | 1155 / 1155 |
stomach | 100% | 5599.72 | 359 / 359 | 100% | 139.81 | 286 / 286 |
thymus | 100% | 7923.99 | 653 / 653 | 100% | 158.85 | 605 / 605 |
uterus | 100% | 9179.89 | 170 / 170 | 100% | 181.80 | 459 / 459 |
prostate | 100% | 11195.13 | 245 / 245 | 100% | 156.17 | 501 / 502 |
ovary | 100% | 7612.68 | 180 / 180 | 100% | 166.05 | 429 / 430 |
liver | 100% | 6483.42 | 226 / 226 | 100% | 102.52 | 405 / 406 |
skin | 100% | 6559.11 | 1808 / 1809 | 100% | 163.99 | 471 / 472 |
intestine | 100% | 7168.12 | 966 / 966 | 100% | 157.02 | 525 / 527 |
brain | 100% | 5270.35 | 2631 / 2642 | 100% | 113.53 | 705 / 705 |
bladder | 100% | 11376.48 | 21 / 21 | 99% | 245.05 | 501 / 504 |
breast | 100% | 8031.92 | 459 / 459 | 99% | 151.79 | 1107 / 1118 |
kidney | 100% | 8586.99 | 89 / 89 | 99% | 119.31 | 889 / 901 |
adrenal gland | 100% | 6569.58 | 258 / 258 | 97% | 153.07 | 223 / 230 |
pancreas | 97% | 3115.48 | 317 / 328 | 99% | 152.10 | 177 / 178 |
adipose | 100% | 8660.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 87.45 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 123.62 | 29 / 29 |
spleen | 100% | 10777.89 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 166.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 398.84 | 1 / 1 |
blood vessel | 100% | 8964.78 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 19897.01 | 926 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 4301.10 | 853 / 861 | 0% | 0 | 0 / 0 |
muscle | 40% | 739.17 | 323 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | SHISA5 |
Protein name | Shisa family member 5 Protein shisa-5 (Scotin) Protein shisa-5 (Putative NF-kappa-B-activating protein 120) (Scotin) |
Synonyms | PSEC0133 SCOTIN |
Description | FUNCTION: Can induce apoptosis in a caspase-dependent manner and plays a role in p53/TP53-dependent apoptosis. . FUNCTION: Can induce apoptosis in a caspase-dependent manner and plays a role in p53/TP53-dependent apoptosis. . |
Accessions | ENST00000415268.1 ENST00000443308.6 [Q8N114-5] ENST00000426002.5 [Q8N114-3] ENST00000296444.7 [Q8N114-1] ENST00000417841.5 F8WDS1 F8WFD9 C9IZ46 ENST00000417962.5 ENST00000424965.5 F8WCE2 ENST00000441507.1 ENST00000619810.4 [Q8N114-2] ENST00000444115.5 [Q8N114-2] H7C2R0 ENST00000442747.5 [Q8N114-2] Q8N114 |